Speed of remission in elderly patients with depression: Electroconvulsive therapy v. medication

Author:

Spaans Harm-Pieter,Sienaert Pascal,Bouckaert Filip,van den Berg Julia F.,Verwijk Esmée,Kho King H.,Stek Max L.,Kok Rob M.

Abstract

BackgroundSevere depression can be a life-threatening disorder, especially in elderly patients. A fast-acting treatment is crucial for this group. Electroconvulsive therapy (ECT) may work faster than medication.AimsTo compare the speed of remission using ECT v. medication in elderly in-patients.MethodThe speed of remission in in-patients with a DSM-IV diagnosis of major depression (baseline MADRS score $20) was compared between 47 participants (mean age 74.0 years, s.d. = 7.4) from an ECT randomised controlled trial (RCT) and 81 participants (mean age 72.2 years, s.d. = 7.6) from a medication RCT (nortriptyline v. venlafaxine).ResultsMean time to remission was 3.1 weeks (s.d. = 1.1) for the ECT group and 4.0 weeks (s.d. = 1.0) for the medication group; the adjusted hazard ratio for remission within 5 weeks (ECT v. medication) was 3.4 (95% CI 1.9–6.2).ConclusionsConsidering the substantially higher speed of remission, ECT deserves a more prominent position in the treatment of elderly patients with severe depression.

Publisher

Royal College of Psychiatrists

Subject

Psychiatry and Mental health

Reference31 articles.

1. Dynamic Prediction of Treatment Response in Late-Life Depression

2. Electroconvulsive therapy vs. paroxetine in treatment-resistant depression — a randomized study

3. Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders - a population based study

4. Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods;Nobler;Convuls Ther,1997

5. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10;Sheehan;J Clin Psychiatry,1998

Cited by 124 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3